Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Medical devices major St. Jude Medical Inc. (STJ - Analyst Report) is voluntarily recalling its Amplatzer TorqVue FX Delivery System because the product could cause fatal injuries to patients. The Food and Drug Administration (FDA) issued a Class I recall of the product, which is considered to be the most serious type of recall.

The device from the company’s Cardiovascular and Ablation Technologies Division was used to precisely implant the Amplatzer occluders to close or seal holes in patient’s hearts. The company had started manufacturing and distributing the delivery system in 2012 but stopped selling it from Jan 2013, when it was found that the core wire could fracture leading to severe consequences. The company also notified its customers to stop using the product immediately.

St. Jude is also trying to solve a manufacturing and quality systems-related problems at its Sylmar facility, which manufactures the highly controversial Riata ST Optim and Durata leads. The company received a warning letter from the FDA in Jan 2013 regarding the problems. The FDA is concerned that the newer generation Durata leads might face the same problem as the Riata leads, which had been recalled by the company in 2011.

The recall of the delivery system further increases concerns regarding the company’s product offerings. St. Jude’s shares dropped by 0.77% to close at $42.60 on Feb 12.

St. Jude’s peer, Stryker Corp. (SYK - Analyst Report) is also facing problems with the recall of its Neptune waste management system, which is likely to dampen sales in its instruments business in 2013.  Health care products major, Covidien plc (COV - Analyst Report) has been hit by a number of product recalls as well, the most significant being the voluntary recall of the Duet offering.

St. Jude has a Zacks Rank #3 (Hold). While we remain on the sidelines regarding St. Jude, medical products companies such as Nuvasive Inc. (NUVA - Snapshot Report), which carries a Zacks Rank #1 (Strong Buy), appear impressive.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%